Atlas Trials

A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function

Clinical trial NCT05674474 · COMPLETED

Trial details

NCT number
NCT05674474
Sponsor
Institut de Recherches Internationales Servier
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2023-03-14
Primary completion
2023-07-18
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.